Articles

• Chronic lymphocytic leukemia: an enigma for both the clinician and the immunologist

  Cristina Scielzo, Michela Frenquelli, Marta Muzio, Maria T.S. Bertilaccio, Antonis Dagklis, Federico Caligaris-Cappio, Paolo Ghia

  https://doi.org/10.4081/hmr.v1i7.626

  373

  PDF: 402

  • PDF

• Moving from clinical to biological staging for the management of chronic lymphocytic leukemia

  Marco Montillo, Alessandra Tedeschi, Sara Miqueleiz, Francesca Ricci, Eleonora Vismara, Enrica Morra

  https://doi.org/10.4081/hmr.v1i7.627

  281

  PDF: 239

  • PDF

• First-line therapy of chronic lymphocytic leukemia: when and how to treat

  Ester M. Orlandi

  https://doi.org/10.4081/hmr.v1i7.628

  205

  PDF: 259

  • PDF

• The role of monoclonal antibodies in the therapeutic strategy of chronic lymphocytic leukemia

  Agostino Cortelezzi

  https://doi.org/10.4081/hmr.v1i7.629

  189

  PDF: 298

  • PDF

• Second line treatment for relapsed chronic lymphocytic leukemia

  Giuseppe Rossi

  https://doi.org/10.4081/hmr.v1i7.630

  203

  PDF: 1363

  • PDF

• Refractory chronic lymphocytic leukemia

  Giovanni Martinelli

  https://doi.org/10.4081/hmr.v1i7.631

  225

  PDF: 437

  • PDF

• Management of complications: infections, autoimmunity, cytopenias

  Fausto Rossini

  https://doi.org/10.4081/hmr.v1i7.632

  212

  PDF: 470

  • PDF